Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Chronic rhinosinusitis is essentially the inflammation of the nasal passage and sinuses and is diagnosed as per the diagnostic criteria of European position paper on Rhinosinusitis and nasal polyps 2020 (EPOS2020). Eosinophilic and non-eosinophilic Chronic rhinosinusitis are defined based on the presence of greater than 10 eosinophils per high power field. This study aimed to study whether the use of preoperative steroids for surgical field preparation actually impacted our diagnosis of eosinophilic vs non-eosinophilic CRS contemplating eosinophils > 10/HPF as the cutoff in accordance with the EPOS2020 guidelines and whether any pathological parameter could be noted to predict recurrence. In this retrospective study a total of 53 patients were included and separated into steroid and non steroid groups based on whether they had received any pre-operative oral steroid preparation. We found that the use of pre operative steroid had no influence on the diagnosis of eosinophilic or non-eosinophilic chronic rhinosinusitis. The study also revealed that lack of neutrophilic infiltrates was a prognosticator for recurrence. Questions about pre-operative steroid preparation and tissue diagnosis have been addressed in some detail in Japan, China and even Korea; our study hints towards a similar truth for the Indian populace and in our review of literature we could not find any other study ascertaining the same for the Indian subcontinent.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12297043PMC
http://dx.doi.org/10.1007/s12070-025-05561-xDOI Listing

Publication Analysis

Top Keywords

chronic rhinosinusitis
12
eosinophilic non-eosinophilic
12
non-eosinophilic chronic
8
diagnosis eosinophilic
8
steroid preparation
8
study
6
steroid
5
devils details
4
details analysis
4
analysis detailed
4

Similar Publications

Background: Criteria for biologic treatment of uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) differ across international recommendations and prescription of biologics depends on national reimbursement criteria. CHRINOSOR offers an opportunity to analyse biologic indications in the real-world setting according to international recommendations.

Methods: CRSwNP patients who received dupilumab treatment in the ENT clinic of 6 tertiary centres (5 countries) were included.

View Article and Find Full Text PDF

Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are common respiratory conditions that significantly impact patient health and contribute to substantial healthcare burdens. While conventional treatments offer symptom relief, many patients continue to experience persistent symptoms, side effects, or resistance to standard therapies. This highlights the growing need for novel, non-invasive, and sustainable therapeutic strategies to manage chronic airway inflammation.

View Article and Find Full Text PDF

Background And Purpose: Biologics are crucial for severe asthma treatment, but their high costs pose challenges. Omalizumab (OML) is dosed on the basis of patient-specific factors. The purpose of this study is to clarify the clinical characteristics of severe asthmatics who maintain long-term control on omalizumab including healthcare cost considerations.

View Article and Find Full Text PDF

Microenvironment-Driven Mast Cell Plasticity: Insights From Cytokine-Activated Gene Signatures in Skin and Respiratory Diseases.

Allergy

September 2025

Department of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK.

Mast cells (MCs) rapidly adapt to the microenvironment due to the plethora of cytokine receptors expressed. Understanding microenvironment-primed immune responses is essential to elucidate the phenotypic/functional changes MCs undergo, and thus understand their contribution to diseases and predict the most effective therapeutic strategies. We exposed primary human MCs to cytokines mimicking a T1/pro-inflammatory (IFNγ), T2/allergic (IL-4 + IL-13), alarmin-rich (IL-33) and pro-fibrotic/pro-tolerogenic (TGFβ) microenvironment.

View Article and Find Full Text PDF

Clinical efficacy of mepolizumab and dupilumab for eosinophilic otitis media: Analysis of patient clinical characteristic.

Allergol Int

September 2025

Department of Otolaryngology/Deafness and Middle Ear Surgicenter, Tokyo Kita Medical Center, Tokyo, Japan; Department of Otolaryngology - Head and Neck Surgery, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Background: Eosinophilic otitis media (EOM) is characterized by eosinophilic infiltration of the middle ear; it is frequently associated with bronchial asthma and chronic rhinosinusitis with nasal polyposis. Although biologics have been used to treat EOM, their efficacy based on clinical characteristics remains unclear. In this study, we evaluated the effectiveness of biologics and analyzed the clinical factors that influenced outcomes.

View Article and Find Full Text PDF